昂利康：双氯芬酸钠肠溶片获得药品注册证书

Core Insights - The company Anglikon (002940) has received regulatory approvals for two pharmaceutical products, enhancing its product pipeline and specifications [1] Group 1 - The company announced the receipt of a drug registration certificate for Diclofenac Sodium Enteric-Coated Tablets [1] - The company also received a supplemental approval notice for Sacubitril/Valsartan Sodium Tablets in the 100mg specification [1] - These approvals are expected to further enrich the company's product offerings [1]